ACHC vs HCA vs ARDT Stock Comparison

Acadia Healthcare Company, HCA Healthcare and Ardent Health Prices as of Nov 13, 2026 Peers: Industry group
HCA HCA Healthcare, Inc.
$499.31 +6.1% 1M +5.5% 1Y
Market cap
$108.91B
P/E
16.1x
Revenue (TTM)
$78.70B
Div. yield
–
Hospitals Healthcare
8 wins
ARDT Ardent Health, Inc.
$17.77 +48.7% 1M +91.1% 1Y
Market cap
$2.52B
P/E
17.3x
Revenue (TTM)
$6.45B
Div. yield
–
Hospitals Healthcare
1 win

Head to Head

11 decided of 12

HCA Healthcare leads on 8 of the 12 questions below (HCA Healthcare 8, Acadia Healthcare Company 2, Ardent Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionACHCHCAARDTLeader
Larger companyMarket capitalisation $3.50B $108.91B $2.52B HCA
Cheaper on earningsLower P/E, profitable companies only -3.1x 16.1x 17.3x HCA
Cheaper on forward earningsLower price / next fiscal year consensus EPS 21.1x 16.2x 17.3x HCA
Faster revenue growthRevenue growth, trailing twelve months +4.5% +5.8% +2.0% HCA
More profitableNet margin, trailing twelve months -33.1% 8.6% 2.3% HCA
Better return on capitalReturn on invested capital -24.6% 21.8% 9.5% HCA
Less leveragedLower net debt / EBITDA -2.5x 3.1x 0.6x ACHC
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +135.0% +5.5% +91.1% ACHC
Better 5-year returnAnnualised price return, 5 years -10.2%/yr +15.3%/yr — HCA
Less volatileAnnualised volatility, 1 year 64.1% 32.7% 49.1% HCA
Higher overall scoreMean of the five percentile scores vs peers 25/100 58/100 65/100 ARDT

Percentile Scorecard

ACHCHCAARDT

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisACHCHCAARDT
Valuation 41 #59 of 99 78 #23 of 99 96 #5 of 99
Growth 2 #87 of 89 24 #68 of 89 26 #66 of 89
Profitability 24 #70 of 92 96 #5 of 92 74 #25 of 92
Financial Health 33 #69 of 103 15 #88 of 103 63 #39 of 103
Shareholder Returns – 81 #13 of 63 65 #23 of 63
Overall 25 58 65
  • ACHC ranked among 103 companies in Healthcare Providers
  • HCA ranked among 103 companies in Healthcare Providers
  • ARDT ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodACHCHCAARDTSPY
1 month +19.3%+6.1%+48.7% -2.0%
3 months +22.5%+23.4%+62.7% -2.8%
6 months +46.4%+18.0%+75.9% +2.0%
Year to date +166.2%+7.0%+101.2% +10.6%
1 year +135.0%+5.5%+91.1% +12.2%
3 years -48.6%+110.2%— +68.1%
3 years, per year -19.9%+28.1%— +18.9%
5 years -41.6%+103.6%— +61.4%
5 years, per year -10.2%+15.3%— +10.1%
10 years -2.6%+617.6%— +248.5%
10 years, per year -0.3%+21.8%— +13.3%

Risk

MeasureACHCHCAARDTSPY
Volatility, 1Y 64.1%32.7%49.1% 13.6%
Downside volatility, 1Y 63.4%30.3%44.8% 13.9%
Beta vs S&P 500, 1Y 0.700.280.29 1.00
Return / volatility, 1Y 2.100.171.86 0.90
Max drawdown, 5Y -86.9%-39.7%-61.2% -25.4%
From 52-week high -2.6%-8.4%-2.3% -3.2%
52-week high $38.80$545.13$18.18 $779.14
52-week low $11.68$361.32$7.83 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleACHCHCAARDT
P/E now vs peer median -3.0xmedian 22.4x 15.8xmedian 22.4x 17.1xmedian 22.4x
P/S now vs peer median 1.0xmedian 1.3x 1.3xmedian 1.3x 0.4xmedian 1.3x
EV/EBITDA now vs peer median -6.4xmedian 14.2x 9.7xmedian 14.2x 5.5xmedian 14.2x
P/FCF now vs peer median -143.9xmedian 19.0x 17.6xmedian 19.0x 8.9xmedian 19.0x
P/B now vs peer median 1.7xmedian 2.6x -13.0xmedian 2.6x 1.4xmedian 2.6x
PEG now vs peer median 0.01median 0.84 1.09median 0.84 —median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsACHCHCAARDT
Revenue $3.41B $78.70B $6.45B
Gross profit $3.29B $67.30B $5.35B
Operating income -$1.08B $12.19B $343.67M
Net income -$1.12B $7.80B $194.40M
Free cash flow -$23.86M $5.97B $282.30M
EPS (diluted) $-12.29 $31.20 $1.03
Cash & equivalents $163.31M $908.00M $766.24M
Total debt $2.35B $50.49B $1.10B
Shares (diluted) 91.75M 217.21M 141.70M
Enterprise value $2.87B $103.27B -$285.65M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricACHCHCAARDT
P/E -3.0x 15.8x 17.1x
P/FCF -143.9x 17.6x 8.9x
P/Operating cash flow 14.6x 9.4x 5.2x
P/S 1.0x 1.3x 0.4x
P/B 1.7x -13.0x 1.4x
P/Tangible book 1.8x -13.0x 1.5x
EV/EBITDA -6.4x 9.7x 5.5x
EV/EBIT -5.2x 12.7x 8.3x
EV/Revenue 1.6x 2.0x 0.4x
EV/FCF -235.7x 25.9x 10.0x
EV/Operating cash flow 23.9x 13.8x 5.9x
PEG (3Y EPS CAGR) 0.01 1.09 –

Growth

14 metrics
MetricACHCHCAARDT
Revenue growth (1Y) 4.5% 5.8% 2.0%
Revenue CAGR (3Y) 6.0% 7.6% –
Gross profit growth (1Y) 4.4% 6.3% 1.7%
Gross profit CAGR (3Y) 6.1% 8.0% –
Operating income growth (1Y) -863.4% 6.0% -17.7%
Operating income CAGR (3Y) -262.5% 4.9% –
Net income growth (1Y) -1,044% 6.8% -16.1%
Net income CAGR (3Y) -350.5% 4.3% –
EPS growth (1Y) -1,137% 16.1% -28.9%
EPS CAGR (3Y) -294.4% 14.6% –
Operating cash flow growth (1Y) -29.8% -13.0% 31.4%
Operating cash flow CAGR (3Y) -20.0% 6.4% –
Free cash flow growth (1Y) 93.1% -26.2% 79.3%
Free cash flow CAGR (3Y) -31.5% 10.9% –

Profitability

14 metrics
MetricACHCHCAARDT
Gross margin 96.4% 85.5% 82.8%
EBITDA margin -25.6% 20.3% 8.0%
Operating margin -31.7% 15.5% 5.3%
Pretax margin -31.7% 12.5% 4.5%
Net margin -33.1% 8.6% 2.3%
FCF margin -0.7% 7.6% 4.4%
Operating cash flow margin 6.9% 14.2% 7.5%
Return on equity -56.1% – 13.1%
Return on assets -20.2% 12.3% 4.3%
Return on invested capital -24.6% 21.8% 9.5%
Return on capital employed -21.6% 28.0% 8.0%
Asset turnover 0.6x 1.2x 1.2x
Cash conversion (OCF / net income) -0.2x 1.4x 2.5x
Stock comp / revenue 1.0% 0.5% 0.5%

Financial Health

11 metrics
MetricACHCHCAARDT
Debt / assets 42.3% 79.6% 20.5%
Debt / equity 1.2x -6.3x 0.6x
Net debt / EBITDA -2.5x 3.1x 0.6x
Debt / FCF -98.6x 8.5x 3.9x
Liabilities / assets 63.6% 112.7% 66.6%
Equity / assets 36.4% -12.7% 33.4%
Interest coverage – 5.2x 6.5x
Current ratio 1.6x 0.8x 2.1x
Quick ratio 1.2x 0.7x 1.4x
Cash ratio 0.3x 0.1x 0.8x
Altman Z-score 0.45 2.52 2.26

Shareholder Returns

7 metrics
MetricACHCHCAARDT
Dividend yield – 0.6% –
Net buyback yield – 8.7% 0.4%
Shareholder yield – 9.3% 0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusACHCHCAARDT
Forward P/E 21.1xFY2026 16.2xFY2026 17.3xFY2026
EPS, next fiscal year $1.79FY2026 $30.83FY2026 $1.03FY2026
EPS growth, next FY -10.5%FY2026 +9.3%FY2026 +7.3%FY2026
EPS growth, the year after +18.4% +6.2% +12.6%
Revenue, next fiscal year $3.55BFY2026 $73.66BFY2026 $6.86BFY2026
Revenue growth, next FY +7.2%FY2026 -2.6%FY2026 +8.5%FY2026
Revenue growth, the year after +7.2% +18.0% +0.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersACHCHCAARDT
Held by institutions 100.0% 59.5% 76.4%
Institutions holding 314 1,339 137
Change in shares held, QoQ +3.7% +0.3% +1.4%
Institutions buying 165 569 87
Institutions selling 98 565 36
Buyers to sellers 1.68 1.01 2.42

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ACHCHCAARDT
ACHC 1.00 0.21 0.25
HCA 0.21 1.00 0.41
ARDT 0.25 0.41 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ACHC, HCA and ARDT?

HCA Healthcare (HCA) is the largest by market capitalisation: Acadia Healthcare Company (ACHC) $3.50B, HCA Healthcare (HCA) $108.91B, Ardent Health (ARDT) $2.52B.

Which stock is cheaper, ACHC, HCA and ARDT?

HCA Healthcare (HCA) trades on the lowest price-to-earnings ratio (Acadia Healthcare Company (ACHC) -3.1x, HCA Healthcare (HCA) 16.1x, Ardent Health (ARDT) 17.3x). On next year's consensus earnings, HCA Healthcare (HCA) is cheapest (Acadia Healthcare Company (ACHC) 21.1x, HCA Healthcare (HCA) 16.2x, Ardent Health (ARDT) 17.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

HCA Healthcare (HCA) grew revenue fastest over the trailing twelve months: Acadia Healthcare Company (ACHC) +4.5%, HCA Healthcare (HCA) +5.8%, Ardent Health (ARDT) +2.0%.

Which company is more profitable?

HCA Healthcare (HCA) has the highest net margin (Acadia Healthcare Company (ACHC) -33.1%, HCA Healthcare (HCA) 8.6%, Ardent Health (ARDT) 2.3%). On return on invested capital, HCA Healthcare (HCA) leads (Acadia Healthcare Company (ACHC) -24.6%, HCA Healthcare (HCA) 21.8%, Ardent Health (ARDT) 9.5%).

Which stock has performed better?

Over the past year Acadia Healthcare Company (ACHC) returned the most: Acadia Healthcare Company (ACHC) +135.0%, HCA Healthcare (HCA) +5.5%, Ardent Health (ARDT) +91.1%. Over five years, HCA Healthcare (HCA) compounded fastest (Acadia Healthcare Company (ACHC) -10.2%/yr, HCA Healthcare (HCA) +15.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, HCA Healthcare (HCA) has been the steadiest (Acadia Healthcare Company (ACHC) 64.1%, HCA Healthcare (HCA) 32.7%, Ardent Health (ARDT) 49.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ACHC, HCA and ARDT?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, HCA Healthcare (HCA) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.